ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Cheops Tech France Eo 10

Cheops Tech France Eo 10 (MLCHE)

63.50
0.00
(0.00%)
Cerrado 05 Enero 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
63.50
Postura de Compra
55.50
Postura de Venta
63.50
Volume Operado de la Acción
6
63.50 Rango del Día 63.50
53.00 Rango de 52 semanas 68.00
Precio Anterior
63.50
Precio de Apertura
63.50
Última hora de negociación
Volumen promedio (3 m)
10
Volumen financiero
-
Precio Promedio Ponderado
-

MLCHE Últimas noticias

CHEOPS TECHNOLOGY UN LEADER FRANÇAIS DU CLOUD ET DE LA DATA AUX RÉSULTATS RECORDS PORTÉS PAR SES INNOVATIONS

CHEOPS TECHNOLOGY UN LEADER FRANÇAIS DU CLOUD ET DE LA DATA AUX RÉSULTATS RECORDS PORTÉS PAR SES INNOVATIONS COMMUNIQUÉ DE PRESSE                                 Bordeaux, le 30 octobre 2024...

CHEOPS TECHNOLOGY FRANCHIT LE CAP DES 200 MILLIONS D’EUROS DE CHIFFRE D’AFFAIRES CONSOLIDÉ

CHEOPS TECHNOLOGY FRANCHIT LE CAP DES 200 MILLIONS D’EUROS DE CHIFFRE D’AFFAIRES CONSOLIDÉ CHEOPS TECHNOLOGY FRANCHIT LE CAP DES 200 MILLIONS D’EUROS DE CHIFFRE D’AFFAIRES CONSOLIDÉ NOMME...

UN EXERCICE 2022 / 2023 CHARNIÈRE POUR CHEOPS TECHNOLOGY

UN EXERCICE 2022 / 2023 CHARNIÈRE POUR CHEOPS TECHNOLOGY COMMUNIQUÉ DE PRESSE                                                                                                                ...

Cheops Technology choisit Nutanix pour renforcer son offre d’infrastructure on premise et de cloud computing

Cheops Technology choisit Nutanix pour renforcer son offre d’infrastructure on premise et de cloud computing Cheops Technology choisit Nutanix pour renforcer son offre d’infrastructure on...

CHEOPS ACQUIERT SOLUTIONDATA POUR RENFORCER SA PRÉSENCE EN OCCITANIE ET DANS LES GRANDS COMPTES AÉRONAUTIQUES

CHEOPS ACQUIERT SOLUTIONDATA POUR RENFORCER SA PRÉSENCE EN OCCITANIE ET DANS LES GRANDS COMPTES AÉRONAUTIQUES Communiqué de presse Le 3 octobre 2023   CHEOPS ACQUIERT SOLUTIONDATA POUR...

CHEOPS TECHNOLOGY récompensé de l’award du Meilleur Partenaire Greenlake par Hewlett Packard Enterprise

CHEOPS TECHNOLOGY récompensé de l’award du Meilleur Partenaire Greenlake par Hewlett Packard Enterprise     COMMUNIQUÉ DE PRESSE CHEOPS TECHNOLOGY RÉCOMPENSÉ DE L’AWARD DU...

CHEOPS TECHNOLOGY - Résultats 2021/2022

CHEOPS TECHNOLOGY - Résultats 2021/2022 Communiqué de presseLe 11 octobre 2022    Un exercice 2021/2022 en ligne avec les attentes Nouvelle croissance du chiffre d’affaires, en hausse de...

CHEOPS TECHNOLOGY : COMMUNIQUÉ DE PRESSE

CHEOPS TECHNOLOGY [Code ISIN : FR0010447086] (« CHEOPS ») (Paris:MLCHE), société dont le siège est à Canéjan en région Bordelaise, Cloud Service Provider et Cloud Builder, spécialiste du Cloud...

CHEOPS TECHNOLOGY annonce la signature d'un contrat de cession d'actions (SPA)

CHEOPS TECHNOLOGY annonce la signature d'un contrat de cession d'actions (SPA) CHEOPS TECHNOLOGY annonce la signature d'un contrat de cession d'actions (SPA) Bordeaux le 22...

CHEOPS TECHNOLOGY ouvre un nouveau chapitre de son histoire en accélérant son développement pour devenir un des leaders européen du Cloud

CHEOPS TECHNOLOGY ouvre un nouveau chapitre de son histoire en accélérant son développement pour devenir un des leaders européen du Cloud CHEOPS TECHNOLOGY ouvre un nouveau chapitre de son...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10063.563.563.500DE
4-0.5-0.78125646463.5963.5DE
1246.7226890756359.564.555.51061.4052901DE
260063.56855.5661.48614776DE
52-1-1.550387596964.56853659.97632576DE
156-13.5-17.5324675325778147.81165.41779954DE
26028.380.397727272735.28729.61756.59834066DE

MLCHE - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cheops Tech France Eo 10?
El precio actual de las acciones de Cheops Tech France Eo 10 es 63.50 €
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cheops Tech France Eo 10?
Cheops Tech France Eo 10 ha negociado en un rango de 53.00 € a 68.00 € durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M
benz280c benz280c 5 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 12 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 12 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 16 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 21 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 22 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 26 minutos hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 29 minutos hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 29 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 32 minutos hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 35 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 38 minutos hace
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 38 minutos hace
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 39 minutos hace
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 40 minutos hace
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 42 minutos hace
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 56 minutos hace
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 57 minutos hace
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII
Jane1999 Jane1999 58 minutos hace
Here the CEO : https://www.wsj.com/market-data/quotes/CA/XCNQ/TWOH/company-people/executive-profile/149699
TWOH
Curious Bystander Curious Bystander 1 hora hace
The Expert Market was set up by the SEC for several very specific reasons. But you could generally say that a security lands in that market when a company is either UNABLE or UNWILLING to file certain SEC-required forms.

UNABLE or UNWILLING. Hmmmm…..I wonder which category Quantum
FLCX
CometNebula81 CometNebula81 1 hora hace
What is everyone's opinion on if or when dividends may be restored and if so what much would we be looking at in dividends? Let's you have 100,000 shares what would you be getting every year?
FNMA
Steady_T Steady_T 1 hora hace
Wouldn't the MABS have to be better than donepezil and memantine to get approved making them the new SOC?

That doesn't mean the MABS are selling well.
AVXL
mrwhippy458 mrwhippy458 1 hora hace
Somewhat true. Once it's at 250m OS, they need to bring that market cap up so we can start seeing dollars
ABQQ
CrossFireTrader CrossFireTrader 1 hora hace
Actually Alocations are given to Dealerships based on how many Vettes they have sold in prior years 25 years ago I lived in Los Angeles and there was a small city Montclair about 10 15 south of Pasadena there was a Dealership there Richard Hibbard Chevrolet and he got more Vettes than anyone in the
GDVM

Su Consulta Reciente

Delayed Upgrade Clock